Ravi S. Chari, SVP-Clinical Excellence at HCA Holdings, Inc. (HCA), sold 31,956 shares at $90.00 ($2.9M) on 2017-03-27, disclosed to the SEC on 2017-03-29.
Open-market sale of $2.9M HCA by SVP-Clinical Excellence. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.